Diagnosis of dementia using perfusion SPECT imaging at the patient's initial visit to a cognitive disorder clinic

Clinical Nuclear Medicine

Volumn 31, Issue 12, 2006, Pages 764-773

  Uchida, Yoshitaka ^a   Minoshima, Satoshi ^b   Okada, Shinichi ^c   Kawata, Tetsuya ^a   Ito, Hisao ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

3D SSP; Dementia; Diagnostic accuracy; NEUROSTAT; SPECT

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; IOFETAMINE I 123;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN PERFUSION; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; ALGORITHMS; AMBULATORY CARE; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33751213360     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000246818.24566.54     Document Type: Article

References (38)

1. Bird TD. Memory loss and dementia. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 2001:148-155.
2. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med. 1992;33:181-185.
3. Johnson KA, Kijewski MF, Becker JA, et al. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med. 1993;34:2044-2048.
4. Jobst KA, Hindley NJ, King E, et al. The diagnosis of Alzheimer's disease: a question of image? J Clin Psychiatry. 1994;55(suppl):22-31.
5. Messa C, Perani D, Lucignani G, et al. High-resolution technetium-99-m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J Nucl Med. 1994;35:210-216.
6. Read SL, Miller BL, Mena I, et al. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc. 1995;43:1243-1247.
7. Bonte FJ, Weiner MF, Bigio EH, et al. Brain blood flow in the dementias: SPECT with histopathologic correlation in 54 patients. Radiology. 1997;201:793-797.
8. Minoshima S, Foster NL, Kuhl DE. Posterior cingulated cortex in Alzheimer's disease. Lancet. 1994;344:895.
9. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42:85-94.
10. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238-1248.
11. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-639.
12. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme; 1988.
13. Minoshima S, Berger KL, Lee KS, et al. An automated method for rotational correction and centering of three-dimensional functional brain images. J Nucl Med. 1992;33:1579-1585.
14. Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med. 1993;34:322-329.
15. Minoshima S, Koeppe RA, Frey KA, et al. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. J Nucl Med. 1994;35:1528-1537.
16. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDA-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
17. Metz CE, Herman BA, Roe CA. Statistical comparison of two ROC-curve estimates obtained from partially-paired datasets. Med Decis Making. 1998;18:110-121.
18. O'Brien JT, Ames D, Desmond P, et al. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls. Int Psychogeriatr. 2001;13:149-161.
19. Karbe H, Kertesz A, Davis J, et al. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT. Neuroradiology. 1994;36:1-6.
20. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med. 1988;29:1507-1514.
21. Van Gool WA, Walstra GJ, Teunisse S, et al. Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography. J Neurol. 1995;242:401-405.
22. Ishii K, Mori E, Kitagaki H, et al. The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT. Clin Nucl Med. 1996;21:106-110.
23. Masterman DL, Mendez MF, Fairbanks LA, et al. Sensitivity, specificity, and positive predictive value of technetium 99-HMPAO SPECT in discriminating Alzheimer's disease from other dementias. J Geriatr Psychiatry Neurol. 1997;10:15-21.
24. Velakoulis D, Lloyd JH. The role of SPECT scanning in a neuropsychiatry unit. Aust N Z J Psychiatry. 1998;32:511-522.
25. Bergman H, Chertkow H, Wolfson C, et al. HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. J Am Geriatr Soc. 1997;45:15-20.
26. Jagust WJ, Johnson KA, Holman BL. SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging. 1995;5(suppl 1):S45-52.
27. Hellman RS, Tikofsky RS, Van Heertum R, et al. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO). Eur J Nucl Med. 1994;21:306-313.
28. Varma AR, Adams W, Lloyd JJ, et al. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand. 2002;105:261-269.
29. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286:2120-2127.
30. Callen DJ, Black SE, Caldwell CB. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPECT. Eur J Nucl Med Mol Imaging. 2002;29:899-906.
31. Bartenstein P, Minoshima S, Hirsch C, et al. Quantitative assessment of cerebral blood flow in patients with Alzheimer's disease by SPECT. J Nucl Med. 1997;38:1095-1101.
32. Burdette JH, Minoshima S, Borght TV, et al. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 1996;198:837-843.
33. Imabayashi E, Matsuda H, Asada T, et al. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT. J Nucl Med. 2004;45:1450-1457.
34. Ishii K, Sakamoto S, Sasaki M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med. 1998;39:1875-1878.
35. Ishii K, Yamaji S, Kitagaki H, et al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology. 1999;53:413-416.
36. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 2001;56:643-649.
37. Pasquier J, Michel BF, Brenot-Rossi I, et al. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2002;29:1342-1348.
38. Lampi Y, Sadeh M, Laker O, et al. Correlation of neuropsychological evaluation and SPECT imaging in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2003;18:288-291.